RaNA Therapeutics logo — Crafting innovative RNA medicines to address rare diseases a...

RaNA Therapeutics

Crafting innovative RNA medicines to address rare diseases and genetic disorders

Founded 2011 United States Cambridge, United States 13 employees Post-IPO Equity Total: $442.63M Biotechnology, Health and Wellness

General Information

Company Name RaNA Therapeutics
Founded Year 2011
Location United States Cambridge, United States
Employees 13
Industries Biotechnology, Health and Wellness
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with RaNA Therapeutics. To contact RaNA Therapeutics, visit translate.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does RaNA Therapeutics compare?

A PDF of RaNA Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting RaNA Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About RaNA Therapeutics

Translate Bio is a biotechnology startup that was founded in 2011. The company's slogan, "Crafting innovative RNA medicines to address rare diseases and genetic disorders," encapsulates its mission. Having secured a substantial $125.00M Post-IPO Equity investment on 24 January 2020, Translate Bio has garnered attention and support from investors. Despite the absence of specific headquarters information and details about the last investment's investors, the sizable funding and its focus on pioneering RNA medicines for rare diseases position Translate Bio as a promising venture in the biotechnology industry.

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $125.00M -
24 Jan 2020
Post IPO Equity $90.00M -
17 Sep 2019
Post IPO Equity $47.45M -
03 May 2019
Series C $42.00M 3
Fidelity, Omega Funds +1
01 Dec 2017
Series C $51.00M 6
Atlas Venture, Fidelity +4
10 Jan 2017
Series B $63.81M 10
MERL Ventures Fund, MRL Ventures Fund +8
23 Jul 2015
Series A $20.70M 6
Atlas Venture, MERL Ventures Fund +4
18 Jan 2012
Venture Round $2.66M -
30 Nov 2011

RaNA Therapeutics Alternatives & Competitors

View All Alternatives
RaNA Therapeutics vs

Autifony are dedicated to developing new medicines to treat rare genetic CNS disorders

Venture round
37 employees
Biotechnology, Health and Wellness
RaNA Therapeutics vs
Aegle Therapeutics
Aegle Therapeutics United States

Developing extracellular vesicle (EV) therapies to address rare and serious diseases and disorders

Convertible Note
7 employees
Biotechnology, Health and Wellness
RaNA Therapeutics vs

Pioneering therapeutic advancements with innovative solutions for rare genetic hemoglobin disorders.

Post-IPO Equity
11-50 employees
Biopharma, Biotechnology

FAQ About RaNA Therapeutics

Crafting innovative RNA medicines to address rare diseases and genetic disorders
RaNA Therapeutics was founded in 2011.
RaNA Therapeutics is headquartered in Cambridge, United States.
RaNA Therapeutics operates in Biotechnology and Health and Wellness.
RaNA Therapeutics has approximately 13 employees.
RaNA Therapeutics has completed 8 funding rounds, raising a total of $442.63M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to RaNA Therapeutics include Autifony Therapeutics, Aegle Therapeutics, Imara, Arcturus Therapeutics, Trefoil Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
RaNA Therapeutics and Autifony Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for RaNA Therapeutics, https://bouncewatch.com/company/translate-bio, updated 12 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes